BFR Therapy After ACL Reconstruction

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: ACL Injury, Quadriceps Muscle Atrophy

In brief

This study is a prospective, double-blinded, randomized control trial examining the effect of blood flow restriction (BFR) therapy on reducing post-operative quadriceps atrophy in patients undergoing anterior cruciate ligament reconstruction (ACLR). Following ACLR, patients will undergo a rehabilitation protocol either w/ BFR therapy or sham BFR therapy.

Key facts

Study ID

NCT03794570

Run by

Steadman Philippon Research Institute

People needed

0

Starts

2018-12-18

Expected to finish

2019-06-01

Last updated by the study team

2019-12-04

Who can join

Age: 14 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 14-70
• Undergoing ACL reconstruction with patellar tendon autograft
• Full weightbearing after surgery
• Surgery performed within 14 days of ACL injury
• No nerve catheter in place

You may not qualify if…

• Meniscal root tears
• radial meniscal tears
• multi-ligament knee injury
• revision ACL reconstruction
• concomitant osteotomies
• concomitant cartilage resurfacing procedures
• fracture preventing full-weightbearing of operated extremity
• previous history of deep vein thrombosis (DVT)
• new nerve injury/findings affecting operative extremity
• active femoral nerve catheter
• nerve block lasting longer than day of surgery
• patients unable to tolerate BFR treatment
• untolerable post-operative pain due to absence of nerve catheter
• proximal thigh girth greater than 34cm
• time to surgery greater than 14 days

Where it is running

• The Steadman Clinic — Vail, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.